dc.contributor.author | Mısırlıoğlu, Naile Fevziye | |
dc.contributor.author | Oruçoğlu, Gülbahar Güler | |
dc.contributor.author | Bıçakhan, Burcu | |
dc.contributor.author | Küçük, Suat Hayri | |
dc.contributor.author | Himmetoğlu, Şölen | |
dc.contributor.author | Sayılı, Sena Baykara | |
dc.contributor.author | Özen, Gülenay Defne | |
dc.contributor.author | Uzun, Hafize | |
dc.date.accessioned | 2025-03-22T16:05:28Z | |
dc.date.available | 2025-03-22T16:05:28Z | |
dc.date.issued | 2025 | en_US |
dc.identifier.citation | Misirlioglu, N. F., Orucoglu, G. G., Bıcakhan, B., Kucuk, S. H., Himmetoglu, S., Sayili, S. B., Ozen, G. D., & Uzun, H. (2025). Evaluation of Thrombomodulin, Heart-Type Fatty-Acid-Binding Protein, Pentraxin-3 and Galectin-3 Levels in Patients with Myocardial Infarction, with and Without ST Segment Elevation. Journal of Clinical Medicine, 14(3), 1015. https://doi.org/10.3390/jcm14031015 | en_US |
dc.identifier.issn | 2077-0383 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12900/624 | |
dc.description.abstract | Background: Medical history, ECG findings and cardiac markers are used in the diagnosis of myocardial infarction (MI). Biomarkers used especially for the diagnosis of MI include high-sensitivity troponins (hsTns), creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), myoglobin, cardiac myosin-binding protein C and new cardiac biomarkers. This study evaluated the levels of serum thrombomodulin (TM), heart-type fatty-acid-binding protein (H-FABP), pentraxin-3 (PTX-3) and galectin-3 (Gal-3) to determine their utility in distinguishing between ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI). Methods: This study included a total of 180 patients (90 patients with acute STEMI and 90 patients with NSTEMI) who presented to the Gaziosmanpa & scedil;a Training and Research Hospital, Cardiovascular Surgery and Emergency Department, with ischemic chest pain lasting longer than 30 min. Ninety healthy volunteers were included as the control group. Results: Serum levels of N-terminal pro-brain natriuretic peptide (NT-proBNP), TM, H-FABP, PTX-3 and Gal-3 were significantly different across the STEMI, NSTEMI and control groups (p < 0.001). Strong positive correlations were observed between NT-proBNP and TM, H-FABP, PTX-3 and Gal-3 in the STEMI group. ROC analysis demonstrated excellent diagnostic accuracy for these biomarkers in distinguishing STEMI from NSTEMI and control groups. Conclusions: Vascular inflammation plays an important role in the pathophysiology of STEMI and NSTEMI. A comprehensive cardiac biomarker panel enhances diagnostic accuracy and risk stratification, particularly when distinguishing between STEMI and NSTEMI. The biomarkers hs-TnI, CK-MB, NT-proBNP, TM, H-FABP, PTX-3 and Gal-3 offer complementary information when used together as a panel. Further research and validation are essential to establish standardized protocols for their widespread use. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | MDPI | en_US |
dc.relation.isversionof | 10.3390/jcm14031015 | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Myocardial infarction | en_US |
dc.subject | STEMI | en_US |
dc.subject | NSTEMI | en_US |
dc.subject | Thrombomodulin | en_US |
dc.subject | Heart-type fatty-acid-binding protein | en_US |
dc.title | Evaluation of Thrombomodulin, Heart-Type Fatty-Acid-Binding Protein, Pentraxin-3 and Galectin-3 Levels in Patients with Myocardial Infarction, with and Without ST Segment Elevation | en_US |
dc.type | article | en_US |
dc.department | İstanbul Atlas Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü | en_US |
dc.contributor.institutionauthor | Uzun, Hafize | |
dc.identifier.volume | 14 | en_US |
dc.identifier.issue | 3 | en_US |
dc.relation.journal | JOURNAL OF CLINICAL MEDICINE | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |